Skip to main content
Caplight Logo









Panorama Medicine

Panorama Medicine

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://panoramamedicine.com

Last Round

Grant

Sep 29, 2023

Total Funding Raised

$4.03M

Company Overview

Panorama Medicine is a biotechnology company that has developed a drug discovery platform integrating genomics, big data, and computing to create therapeutic interventions for RNA defects in disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug discoveryRNA therapeuticscomputational biologyRNA splicingAI drug discoveryin silico drug designprecision medicinebiotech platformgenomicstherapeutic target identificationRNA-modulating therapeuticsAI-driven discoverydrug development partnershipgenetic disease research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Panorama Medicine Comparables

Compare Panorama Medicine with similar companies based on industry and business-model similarity.

Panorama Medicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Envisagenics
84%
Serna Bio
82%
Anima Biotech
81%

Panorama Medicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 29, 2023
SeedApr 16, 2019

Panorama Medicine Investors

Notable investors and investment history

Panorama Medicine investors
InvestorRounds
NIH RADxGrant
WI Harper GroupSeed
Amino CapitalSeed
Delian CapitalSeed
5Y CapitalSeed
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors increased 45% MoM.

  • Sep 29, 2023

    $334K grant from the National Institutes of Health (NIH).

Panorama Medicine Filings

Explore SEC and related filing metadata, where available.

Panorama Medicine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Panorama Medicine's valuation, stock price, and market status.

Is Panorama Medicine a public or private company?

Panorama Medicine is a private company.

What is the current stock price of Panorama Medicine?

Panorama Medicine is a private company with no public stock price. No recent secondary market data is available.

How much is Panorama Medicine worth (valuation)?

Valuation information for Panorama Medicine is not publicly available.

Can I buy Panorama Medicine stock?

Panorama Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Panorama Medicine's last funding round?

Panorama Medicine's most recent funding round was Grant on September 29, 2023.

Who are the main investors in Panorama Medicine?

Key investors in Panorama Medicine include WI Harper Group.

Will Panorama Medicine IPO soon?

No public IPO plans have been announced for Panorama Medicine.

How can I track Panorama Medicine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Panorama Medicine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range1
Year Founded2018
Last FundingSep 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?